Log In
Print this Print this

Cobas EGFR Mutation Test v2

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionIn vitro diagnostic test that detects 42 mutations across the EGFR gene, including T790M, exon 19 deletion and L858R substitution
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics: Biomarkers and companion diagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect EGFR mutations, including T790M, in patients with non-small cell lung cancer (NSCLC)
Regulatory Designation
PartnerAstraZeneca plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today